Skip to main content
Clinical Trials/IRCT20200127046282N1
IRCT20200127046282N1
Recruiting
Phase 3

Evaluating the effect of administration of intrathecal Dexmedetomidine on the Spinal Cord Mori levels of apoptotic factors in patients scheduled for lumbar disc surgery

Vice chancellor for research, Shahid Beheshti University of Medical Sciences , Loghman Hospital0 sites40 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Vice chancellor for research, Shahid Beheshti University of Medical Sciences , Loghman Hospital
Enrollment
40
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Shahid Beheshti University of Medical Sciences , Loghman Hospital

Eligibility Criteria

Inclusion Criteria

  • No history of taking anti\-inflammatory drugs two weeks before surgery
  • Lack of AIDS and immunosuppressive diseases

Exclusion Criteria

  • GCS reduction for a reason other than stroke
  • Change in the type of surgery according to the surgeon's opinion
  • History of systemic diseases such as diabetes mellitus, renal failure and chronic pulmonary heart disease

Outcomes

Primary Outcomes

Not specified

Similar Trials